Jennifer Ruff
Investor Relations Contact chez DIANTHUS THERAPEUTICS, INC.
Postes actifs de Jennifer Ruff
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Investor Relations Contact | 29/11/2023 | - |
Historique de carrière de Jennifer Ruff
Anciens postes connus de Jennifer Ruff
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PYXIS ONCOLOGY, INC. | Investor Relations Contact | 01/01/2023 | 01/11/2023 |
| TESARO INC | Investor Relations Contact | 01/03/2013 | 01/10/2018 |
| Public Communications Contact | 01/03/2013 | 01/10/2018 | |
| PFIZER, INC. | Investor Relations Contact | 01/06/2007 | 01/03/2013 |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Public Communications Contact | 01/04/2003 | 01/05/2007 |
Formation de Jennifer Ruff
| Northwestern University | Graduate Degree |
| University of Iowa | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Investor Relations Contact | 4 |
| Public Communications Contact | 2 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
MGI PHARMA Biologics, Inc.
MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Jennifer Ruff
- Expérience
